In appreciation of Sir Philip Randle: The glucose-fatty acid cycle

British Journal of Nutrition

Volumn 97, Issue 5, 2007, Pages 809-813

  Sugden, Mary C ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Glucose; Insulin; Insulin resistance; Lipid; Nuclear hormone receptors; Peroxisome proliferator activated receptors; Signalling; Type 2diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 40; G PROTEIN COUPLED RECEPTOR 40 AGONIST; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; SKELETAL MUSCLE;

FATTY ACIDS; GENE EXPRESSION; GLUCOSE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; METABOLIC NETWORKS AND PATHWAYS; PORTRAITS AS TOPIC;

EID: 34147093330     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507659054     Document Type: Article

References (31)

1. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA & Wakil SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291, 2613-2616.
2. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J & Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11, 183-190.
3. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J & Semenkovich CF (2005) 'New' hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1, 309-322.
4. Desvergne B, Michalik L & Wahli W (2006) Transcriptional regulation of metabolism. Physiol Rev 86, 465-514.
5. Eberle D, Hegarty B, Bossard P, Ferre P & Foufelle F (2004) SREBP transcription factors: Master regulators of lipid homeostasis. Biochimie 86, 839-848.
6. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW & Cooney GJ (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279, E554-E560.
7. Finck BN (2006) Effects of PPARalpha on cardiac glucose metabolism: A transcriptional equivalent of the glucose-fatty acid cycle? Expert Rev Cardiovasc Ther 4, 161-171.
8. Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201-1210.
9. Frayn KN (2003) The glucose-fatty acid cycle: A physiological perspective. Biochem Soc Trans 31, 1115-1119.
10. Garland PB, Newsholme EA & Randle PJ (1962) Effect of fatty acids, ketone bodies, diabetes and starvation on pyruvate metabolism in rat heart and diaphragm muscle. Nature 195, 381-383.
11. Gromada J (2006) The free fatty acid receptor GPR40 generates excitement in pancreatic beta-cells. Endocrinology 147, 672-673.
12. Hegarty BD, Furler SM, Ye J, Cooney GJ & Kraegen EW (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178, 373-383.
13. Holness MJ, Fryer LG & Sugden MC (1997) Endocrine and nutritional modulation of glucose disposal and storage in muscle. Biochem Soc Trans 25, 1-7.
14. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B & Wahli W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103, 1489-1498.
15. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE & Shulman GI (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108 437-446.
16. Koyama K, Chen G, Lee Y & Unger RH (1997) Tissue triglycerides, insulin resistance, and insulin production: Implications for hyperinsulinemia of obesity. Am J Physiol 273, E708-E713.
17. Leone TC, Weinheimer CJ & Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: The PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96, 7473-7478.
18. McGarry JD (1998) Glucose-fatty acid interactions in health and disease. Am J Clin Nutr 67, 500S-504S.
19. Muoio DM & Newgard CB (2006) Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75, 367-401.
20. Perseghin G, Petersen K & Shulman GI (2003) Cellular mechanism of insulin resistance: Potential links with inflammation. Int J Obes Relat Metab Disord 27, Suppl. 3, S6-S11.
21. Poitout V & Robertson RP (2002) Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143, 339-342.
22. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT & Corkey BE (1992) Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267 5802-5810.
23. Randle PJ (1998) Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14, 263-283.
24. Randle PJ, Garland PB, Hales CN & Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
25. Ruderman NB, Saha AK & Kraegen EW (2003) Minireview: Malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144 5166-5171.
26. Saha AK & Ruderman NB (2003) Malonyl-CoA and AMP-activated protein kinase: An expanding partnership. Mol Cell Biochem 253, 65-70.
27. Sugden MC & Holness MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53, Suppl. 1, S71-S81.
28. Sugden MC & Holness MJ (2006) Skeletal muscle lipid metabolism and the adipo-muscular axis. Future Lipidology 1, 153-162.
29. Summers SA & Nelson DH (2005) A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54, 591-602.
30. Thompson AL & Cooney GJ (2000) Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes 49, 1761-1765.
31. Zammit VA (1999) The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. Biochem J 343, 505-515.